Tactile Systems Technology price to free cash flow TCMD
Market value divided by free cash flow over the last twelve months, since 2017.
- Today, Nov 2, 2026
- 19.3×
- 9-year median
- 19.3×
- Against its 9-year history
- 50th
- percentile: 0 is its lowest day, 100 its highest
- 9-year range
- 5.8× to 375×
- Peer median
- 12.3×
Tactile Systems Technology's price to free cash flow is 19.3× as of Nov 2, 2026.
That is at its 9-year median of 19.3×, close to the middle of its last 9 years.
Over that time it ranged from 5.8× in May 2025 to 375× in Feb 2019.
The median for 10 medical instruments and supplies stocks of a similar size is 12.3×.
Price to free cash flow over time
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 19.3× | 12.7× | 20.4× |
| 2025 | 16.8× | 5.8× | 16.8× |
| 2024 | 10.4× | 7.7× | 18.6× |
| 2023 | 16.9× | 12.7× | 110× |
| 2022 | 53.2× | 39.7× | 111× |
| 2021 | 109× | 95.7× | 133× |
| 2020 | n/m a value too high to mean anything | ||
| 2019 | 126× | 114× | 375× |
| 2018 | 221× | 213× | 316× |
| 2017 | 213× | 63.4× | 278× |
Against its peers
Companies in Medical - Instruments & Supplies nearest Tactile Systems Technology's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| TCMDTactile Systems Technology | 19.3× |
| MOVMovado | 10.0× |
| EMBCEmbecta | 2.1× |
| INFUInfuSystem | 12.0× |
| IRMDIradimed | 38.9× |
| IARTIntegra Lifesciences | 12.3× |
| BVSBioventus | 11.7× |
| UTMDUtah Medical Products | 19.6× |
| STAAStaar Surgical | n/m |
| CDRECadre | 17.3× |
| EYENational Vision | 27.6× |
| Peer median | 12.3× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on Tactile Systems Technology
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.